SCHEDULE OF STOCK OPTIONS (Details)	9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares
Equity [Abstract]
Number of Shares, Outstanding at beginning | shares	929,765
Weighted Average Exercise Price, Outstanding at beginning	$ 1.53
Weighted Average Grant Date Fair Value, Outstanding at beginning	$ 2.50
Number of Shares, Granted | shares	80,000
Weighted Average Exercise Price, Granted	$ 3.50
Weighted Average Grant Date Fair Value, Granted	$ 2.81
Number of Shares,Options assumed pursuant to acquisition of Magic Med | shares	973,840
Weighted Average Exercise Price, Options assumed pursuant to acquisition of Magic Med	$ 1.34
Weighted Average Grant Date Fair Value, Options assumed pursuant to acquisition of Magic Med	$ 1.83
Number of Shares, Exercised | shares	(143,796)
Weighted Average Exercise Price, Exercised	$ 0.23
Weighted Average Grant Date Fair Value, Exercised	$ 5.69
Number of Shares, Expired, forfeited, or cancelled | shares	(692,475)
Weighted Average Exercise Price, Expired, forfeited, or cancelled	$ 1.69
Weighted Average Grant Date Fair Value, Expired, forfeited, or cancelled	$ 1.98
Number of Shares, Outstanding at end | shares	1,147,334
Weighted Average Exercise Price, Outstanding at end	$ 1.57
Weighted Average Grant Date Fair Value, Outstanding at end	$ 2.09
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	5 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding | $	$ 730,438
Number of Shares, Exercisable at ending | shares	931,810
Weighted Average Exercise Price, Exercisable at ending	$ 1.52
Weighted Average Grant Date Fair Value, Exercisable	$ 2.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	4 years 10 months 24 days
Aggregate Intrinsic Value, Exercisable | $	$ 550,191